Induction of methionine sulfoxide reductase activity by pergolide, pergolide sulfoxide, and S-adenosyl-methionine in neuronal cells

Jade M. Franklin,Gonzalo A. Carrasco,Jackob Moskovitz

DOI: https://doi.org/10.1016/j.neulet.2012.11.017

IF: 3.197

2013-01-01

Neuroscience Letters

Abstract:The reduction of methionine sulfoxide in proteins is facilitated by the methionine sulfoxide reductase (Msr) system. The Msr reduction activity is important for protecting cells from oxidative stress related damages. Indeed, we have recently shown that treatment of cells with N-acetyl-methionine sulfoxide can increase Msr activity and protect neuronal cells from amyloid beta toxicity. Thus, in search of other similar Msr-inducing molecules, we examined the effects of pergolide, pergolide sulfoxide, and S-adenosyl-methionine on Msr activity in neuronal cells. Treatment of neuronal cells with a physiological range of pergolide and pergolide sulfoxide (0.5-1.0 μM) caused an increase of about 40% in total Msr activity compared with non-treated control cells. This increase in activity correlated with similar increases in methionine sulfoxide reductase A protein expression levels. Similarly, treatment of cells with S-adenosyl methionine also increased cellular Msr activity, which was milder compared to increases induced by pergolide and pergolide sulfoxide. We found that all the examined compounds are able to increase cellular Msr activity to levels comparable to N-acetyl-methionine sulfoxide treatment. Pergolide, pergolide sulfoxide, and S-adenosyl methionine can cross the blood-brain barrier. Therefore, we hypothesize that they can be useful in the treatment of symptoms/pathologies that are associated with reduced Msr activity.

neurosciences

What problem does this paper attempt to address?

This paper aims to explore the effects of certain small - molecule compounds on the activity of methionine sulfoxide reductase (Msr) in nerve cells. Specifically, the researchers investigated the roles of pergolide, pergolide sulfoxide, and S - adenosyl - methionine (SAM) in nerve cells. These compounds can all cross the blood - brain barrier and thus may have potential value in treating brain diseases related to oxidative stress, such as Alzheimer's disease.

### Research Background
- **Methionine Sulfoxide Reductase (Msr) System**: Composed of two enzymes, MsrA and MsrB, it can reduce methionine sulfoxide in proteins to its S - form or R - form, thereby protecting cells from oxidative stress damage.
- **Research Motivation**: Previous studies have shown that N - acetylmethionine sulfoxide can increase Msr activity and protect nerve cells from the toxic effects of β - amyloid protein. Therefore, the researchers hope to find other similar Msr - inducing molecules.

### Research Methods
- **Cell Culture**: Use the nerve cell line CLU213 expressing dopamine, serotonin, and cannabinoid receptors.
- **Treatment Conditions**: Cells were treated with different concentrations of pergolide, pergolide sulfoxide, and S - adenosyl - methionine for 24 hours.
- **Detection Methods**: Msr activity was measured by analyzing the production of dabsyl - Met by HPLC, and the expression levels of MsrA and MsrB were analyzed by Western Blot.

### Main Findings
- **Pergolide and Pergolide Sulfoxide**: At physiological concentrations (0.5 - 1.0 μM), these two compounds significantly increased the total Msr activity, up to approximately 140%. At the same time, the expression level of MsrA protein also increased correspondingly.
- **S - Adenosyl - Methionine**: An increase in Msr activity was observed at a lower concentration (0.1 μM), but the overall effect was slightly lower than that of pergolide and pergolide sulfoxide.

### Conclusions
- **Physiological Significance**: These compounds can increase the antioxidant capacity of nerve cells by increasing Msr activity, and thus may have potential application value in treating brain diseases related to oxidative stress, such as Alzheimer's disease.
- **Future Directions**: Further study whether these compounds induce Msr activity through similar signal transduction pathways and explore other possible Msr - inducing molecules.

In conclusion, this study is the first to prove that certain small - molecule compounds can effectively up - regulate Msr activity in nerve cells at physiological concentrations, which provides new possibilities for the development of new antioxidant drugs.